A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)

PHASE2RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

September 19, 2025

Primary Completion Date

February 5, 2027

Study Completion Date

October 25, 2028

Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG

Nivolumab

Specified dose on specified days

DRUG

Ipilimumab

Specified dose on specified days

DRUG

Carboplatin

Specified dose on specified days

DRUG

Paclitaxel

Specified dose on specified days

DRUG

Pemetrexed

Specified dose on specified days

DRUG

Cisplatin

Specified dose on specified days

Trial Locations (50)

2013

NOT_YET_RECRUITING

Local Institution - 0031, Soweto

2196

NOT_YET_RECRUITING

Local Institution - 0009, Sandton

7700

NOT_YET_RECRUITING

Local Institution - 0084, Rondebosch

12462

NOT_YET_RECRUITING

Local Institution - 0013, Chaïdári

18103

RECRUITING

Lehigh Valley Health Network, Allentown

21079

RECRUITING

Centre Georges François Leclerc, Dijon

24127

RECRUITING

Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo

28100

RECRUITING

Azienda Ospedaliero Universitaria Maggiore della Carità, Novara

33100

RECRUITING

"P.O. S. Maria della Misericordia Azienda Sanitaria Universitaria Friuli Centrale", Udine

34214

NOT_YET_RECRUITING

Local Institution - 0071, Istanbul

41110

NOT_YET_RECRUITING

Local Institution - 0014, Larissa

44106

NOT_YET_RECRUITING

Local Institution - 0047, Cleveland

44109

NOT_YET_RECRUITING

Local Institution - 0033, Cleveland

44630

NOT_YET_RECRUITING

Local Institution - 0025, Guadalajara

47014

RECRUITING

"IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori", Meldola

50134

RECRUITING

Azienda Ospedaliera Universitaria Careggi, Florence

64460

NOT_YET_RECRUITING

Local Institution - 0058, Monterrey

72424

NOT_YET_RECRUITING

Local Institution - 0022, Puebla City

75014

NOT_YET_RECRUITING

Local Institution - 0010, Paris

83702

NOT_YET_RECRUITING

Local Institution - 0063, Boise

83706

NOT_YET_RECRUITING

Local Institution - 0052, Boise

83854

NOT_YET_RECRUITING

Local Institution - 0064, Post Falls

90033

NOT_YET_RECRUITING

Local Institution - 0062, Los Angeles

92151

RECRUITING

Hôpital Foch, Suresnes

92663

NOT_YET_RECRUITING

Local Institution - 0088, Newport Beach

97070

NOT_YET_RECRUITING

Local Institution - 0027, Mérida

99508

RECRUITING

Alaska Oncology and Hematology, Anchorage

200542

RECRUITING

"Centrul de Oncologie Sfântul Nectarie", Craiova

400015

RECRUITING

Institutul Oncologic Cluj, Cluj-Napoca

407280

RECRUITING

SC Radiotherapy Center Cluj SRL, Florești

700483

RECRUITING

Institutul Regional de Oncologie, Iași

1240000

NOT_YET_RECRUITING

Local Institution - 0068, Antofagasta

2520598

NOT_YET_RECRUITING

Local Institution - 0069, Viña del Mar

8420383

NOT_YET_RECRUITING

Local Institution - 0067, Santiago

14784400

NOT_YET_RECRUITING

Local Institution - 0037, Barretos

70200-730

NOT_YET_RECRUITING

Local Institution - 0041, Brasília

30380-490

NOT_YET_RECRUITING

Local Institution - 0043, Belo Horizonte

90035-903

NOT_YET_RECRUITING

Local Institution - 0038, Porto Alegre

01246-000

NOT_YET_RECRUITING

Local Institution - 0034, São Paulo

115 27

RECRUITING

"Thoracic General Hospital of Athens I Sotiria", Athens

540 07

NOT_YET_RECRUITING

Local Institution - 0011, Thessaloniki

06700

NOT_YET_RECRUITING

Local Institution - 0024, México

03-411

NOT_YET_RECRUITING

Local Institution - 0081, Warsaw

82-550

RECRUITING

Szpital Specjalistyczny w Prabutach Spolka z o.o., Prabuty

93-338

RECRUITING

Instytut Centrum Zdrowia Matki Polki, Lodz

022328

RECRUITING

Institutul Oncologic Bucuresti, Bucharest

020335

RECRUITING

Centrul de Diagnostic si Tratament Provita, Bucharest

0181

WITHDRAWN

Local Institution - 0066, Pretoria

01140

NOT_YET_RECRUITING

Local Institution - 0070, Adana

06010

NOT_YET_RECRUITING

Local Institution - 0072, Ankara

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06946797 - A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter